Press Releases
Our team at Pharmafocuseurope.com believes that press releases are an important marketing tool for highlighting a client's corporate message and ensuring it reaches their target audience. The feature can be used to publish business agreements, annual reports, financial results, corporate performances, important announcements, and any other important information that needs to be communicated to the target audience. Pharma companies can also use it to launch new products and promote existing ones.
IQVIA and Kexing Biopharm Expand Strategic Collaboration to Accelerate Global Biosimilar Development using AI-Enabled Capabilities
Friday, May 15, 2026IQVIA a leading global provider of clinical research services commercial insights and healthcare intelligence to the life sciences and healthcare industries is advancing its strategic collaboration with Kexing Biopharm
Vetter Starts Construction of a New Production Site in Germany
Thursday, May 14, 2026Vetter a leading Contract Development and Manufacturing Organization CDMO is celebrating the start of construction on its new site in Saarlouis with a traditional groundbreaking ceremony today
Nuclera Launches Antibody Triage Service to Advance AI-Driven Antibody Discovery
Tuesday, May 12, 2026Nuclera the biotechnology company enabling rapid access to highquality proteins today announced the launch of its antibody screening service to streamline the transition from antibody hit generation to lead selection
Innovent Announces IBI363 (PD-1/IL-2α-bias Bispecific Fusion Protein) Received Third NMPA Breakthrough Therapy Designation for MSS/pMMR Metastatic Colorectal Cancer
Tuesday, May 12, 2026Innovent Biologics Inc Innovent HKEX a worldclass biopharmaceutical company that develops manufactures and commercializes highquality medicines for the treatment of oncology autoimmune cardiovascular
Flex Databases Introduces TMF Blinding to Simplify Management of Blinded Clinical Trials
Tuesday, May 12, 2026Flex Databases has announced the release of TMF Blinding a new feature within its Trial Master File platform designed to help clinical teams manage blinded studies without the operational complexity
Erasca Announces Clinical Trial Collaboration and Supply Agreement with Merck to Evaluate ERAS-0015 in Combination with KEYTRUDA® (Pembrolizumab)
Tuesday, May 12, 2026Erasca Inc Nasdaq ERAS a clinicalstage precision oncology company singularly focused on discovering developing and commercializing therapies for patients with RASMAPK pathwaydriven cancers
AGC Biologics Joins Orphan Therapeutics Accelerator’s Clinical Development Network as a Manufacturing Partner to Advance Cell and Gene Therapies for Ultra-Rare Diseases
Tuesday, May 12, 2026Orphan Therapeutics Accelerator OTXL a nonprofit biotech focused on completing development and enabling commercial access to stalled rare disease treatments today announced that AGC Biologics
Chance Pharma Announces NMPA Acceptance of New Drug Application for Investigational Respiratory Drug CXG87
Monday, May 11, 2026Chance Pharmaceuticals a clinicalstage biotechnology company dedicated to the research and development of innovative inhalation therapies today announced that the Center for Drug Evaluation of Chinas National Medical
ACROBiosystems Launches Global License Solution Upgrade for HEK293 Functional Cell Lines, Streamlining Compliance to Accelerate Biopharmaceutical R&D
Monday, May 11, 2026ACROBiosystems announced a major upgrade to its global license solution for HEK functional cell lines Centered on customer value and empowering global biopharmaceutical innovation
Sino Biological Unveils EliteScience VIP Partnership Program for European Researchers
Monday, May 11, 2026Sino Biological Europe GmbH the regional subsidiary of global life science reagent and service provider Sino Biological has recently launched its EliteScience VIP Partnership program an exclusive premium service
